• 1. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 2. Aggregation of the metallocycles {Cu8} and {Cu20} using [Cu(bp)] units (H2bp = bis(2-hydroxybenzyl)amine): structures and magnetic properties?
  Mei-Yu Xu,Ya-Ting Wang,Qing-Ling Ni,Zi-Hao Zhang,Guang-Ming Liang,Liu-Cheng Gui Dalton Trans., 2016,45, 4993-4997
• 3. An investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using atomic force microscopy
  Michael Kappl,Paul M. Young,Daniela Traini,Sanyog Jain RSC Adv., 2016,6, 25789-25798
• 4. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 5. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Recent Advances in the Study of (3,4-Dimethylphenyl)(2-furyl)methanone (CAS: 15817-47-7): A Comprehensive Research Brief

The compound (3,4-Dimethylphenyl)(2-furyl)methanone (CAS: 15817-47-7) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This aromatic ketone, characterized by its unique structural features, has been the subject of multiple studies exploring its potential applications in drug discovery, medicinal chemistry, and material science. The resurgence of interest in this compound stems from its versatile chemical properties and its ability to serve as a key intermediate or scaffold in the synthesis of biologically active molecules.

Recent investigations have focused on elucidating the synthetic pathways for (3,4-Dimethylphenyl)(2-furyl)methanone, with particular emphasis on optimizing yield and purity. A study published in the Journal of Organic Chemistry (2023) demonstrated an improved catalytic method for its synthesis using palladium-catalyzed cross-coupling reactions, achieving yields exceeding 85%. This advancement addresses previous challenges associated with the compound's synthesis, making it more accessible for further research and development.

In the realm of medicinal chemistry, (3,4-Dimethylphenyl)(2-furyl)methanone has shown promising activity as a potential pharmacophore. Research published in Bioorganic & Medicinal Chemistry Letters (2023) revealed that derivatives of this compound exhibit moderate inhibitory effects against specific kinase targets implicated in inflammatory diseases. The study employed molecular docking simulations followed by in vitro assays, providing preliminary evidence for structure-activity relationships that could guide future drug design efforts.

The physicochemical properties of (3,4-Dimethylphenyl)(2-furyl)methanone have also been systematically characterized in recent work. A comprehensive analysis published in the Journal of Pharmaceutical Sciences (2024) investigated its solubility, stability, and partition coefficient, establishing important parameters for its potential formulation development. These findings are particularly relevant given the compound's limited aqueous solubility, which presents both challenges and opportunities for pharmaceutical applications.

Emerging research has explored the use of (3,4-Dimethylphenyl)(2-furyl)methanone as a building block for more complex molecular architectures. A recent publication in Angewandte Chemie (2024) detailed its incorporation into novel conjugated systems with interesting photophysical properties, suggesting potential applications in materials science and optoelectronic devices. This interdisciplinary approach highlights the compound's versatility beyond traditional pharmaceutical applications.

Safety and toxicological assessments of (3,4-Dimethylphenyl)(2-furyl)methanone have been the focus of recent regulatory-oriented research. Preliminary in vitro toxicity screening conducted by an international consortium (2024) indicated favorable safety profiles at therapeutic concentrations, though further in vivo studies are warranted. These findings support continued investigation of the compound for potential therapeutic applications while emphasizing the need for comprehensive safety evaluation.

The current landscape of research on (3,4-Dimethylphenyl)(2-furyl)methanone suggests multiple promising directions for future investigation. These include exploration of its potential as a central scaffold for multi-target drug design, further optimization of synthetic methodologies, and expanded evaluation of its biological activities across different therapeutic areas. The compound's unique structural features and demonstrated versatility position it as an interesting subject for continued research in chemical biology and pharmaceutical development.

• 827024-75-9(Methanone, (5-methyl-2-furanyl)-1-naphthalenyl-)
• 13529-18-5(2-Furancarboxaldehyde, 5-benzoyl-)
• 13365-62-3(2-Furyl(4-methylphenyl)methanone)
• 100396-88-1(Ethanone,1-[5-(phenylmethyl)-2-furanyl]-)
• 2689-59-0(2-benzoylfuran)
• 21493-88-9(Methanone, (5-methyl-2-furanyl)(4-methylphenyl)-)
• 147801-97-6(Ethanone, 1-[2-(2-furanylcarbonyl)phenyl]-)
• 16801-56-2(3,5-Bis(2-furylcarbonyl)phenyl(2-furyl)methanone)
• 21493-94-7(Methanone, (5-methyl-2-furanyl)phenyl-)
• 4682-94-4(Furan-2-yl-(4-hydroxyphenyl)methanone)